OraGraft® is a premium allogenic bone graft substitute developed by LifeNet Health, a globally recognized leader in tissue and cellular therapy. Designed to support optimal bone regeneration, OraGraft® is widely used in dental, craniofacial, and orthopedic procedures, providing surgeons and clinicians with a reliable and safe alternative to autogenous bone grafts.
Key Features and Benefits Allogenic and Biologically Safe: Sourced from carefully screened human donors, OraGraft® undergoes rigorous processing to ensure sterility while maintaining the natural osteoconductive and osteoinductive properties of bone. Versatile Clinical Applications: Ideal for sinus augmentation, alveolar ridge preservation, periodontal defect repair, and craniofacial reconstruction, OraGraft® adapts to various surgical needs. Convenient Storage and Handling: Offered in particulate form, OraGraft® can be stored at ambient temperature with an extended shelf life, simplifying inventory management for clinics. Enhanced Healing: The demineralized cortical matrix in OraGraft® supports natural bone remodeling and integration, promoting faster and predictable outcomes for patients. Commitment to Quality
LifeNet Health adheres to the highest standards of tissue banking and quality assurance. OraGraft® is processed under strict protocols to achieve sterility assurance levels of 10⁻⁶, ensuring that every graft meets rigorous safety and performance standards.
Clinical Excellence
With its combination of safety, versatility, and proven biological performance, OraGraft® has become a trusted solution for clinicians seeking effective bone regeneration without the limitations and morbidity associated with autografts. Its ease of use and predictable results make it a preferred choice in modern dental and surgical practices worldwide.
OraGraft® – Supporting the next generation of bone regeneration.
